Cdc42 regulates LPS-induced proliferation of primary pulmonary microvascular endothelial cells via ERK pathway
After stimulation due to injury, cell division cycle protein 42 (Cdc42) restores and enhances barrier functions by strengthening intercellular adherens junctions; however, its influence on cell proliferation after injury remains unknown. In this study, we sought to investigate the effect of stimulat...
Gespeichert in:
Veröffentlicht in: | Microvascular research 2017-01, Vol.109, p.45-53 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | After stimulation due to injury, cell division cycle protein 42 (Cdc42) restores and enhances barrier functions by strengthening intercellular adherens junctions; however, its influence on cell proliferation after injury remains unknown.
In this study, we sought to investigate the effect of stimulation using small doses of lipopolysaccharide (LPS) on the proliferation of pulmonary microvascular endothelial cells (PMVECs).
We stimulated PMVECs with different doses of LPS and evaluated the effects on cell proliferation. We also constructed a primary gene-knockout cell line lacking Cdc42 to verify the role of Cdc42 in regulating the proliferation of PMVECs that were stimulated using LPS and to explore related signaling pathways.
Stimulating PMVECs with small doses of LPS increased proliferation. Cdc42 is involved in regulating this process, which was mediated by the extracellular regulated protein kinase (ERK) pathway.
Cdc42 plays a role in regulating the proliferation of PMVECs stimulated with small doses of LPS, and this regulation involves the ERK pathway.
•Low concentration of lipopolysaccharides (LPS) may induce pulmonary microvascular endothelial cells (PMVECs) proliferation.•Deletion of Cdc42 inhibits LPS-induced PMVECs proliferation.•Cdc42 mediates PMVECs proliferation via ERK pathway. |
---|---|
ISSN: | 0026-2862 1095-9319 |
DOI: | 10.1016/j.mvr.2016.10.001 |